Scientists at EPFL have developed “lymphomoids,” a pioneering cancer model that preserves the structure and multicellular composition of lymphoma tumors in the lab. Lymphomoids offer an innovative way to test the efficacy of lymphoma treatments and better predict individual responses.
Medical Xpress – latest medical and health news stories
